Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable nos substrate-to-inhibitor ratio: The Hoorn study

Clinical Science

Volumn 121, Issue 2, 2011, Pages 71-78

  van der Zwan, Leonard P ^a   Scheffer, Peter G ^a   Dekker, Jacqueline M ^a   Stehouwer, Coen D A ^b   Heine, Robert J ^a   Teerlink, Tom ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Asymmetric NG,NG dimethylarginine (ADMA); C reactive protein (CRP); Inflammation; Myeloperoxidase (MPO); NO synthase (NOS); Oxidative stress

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGININE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BIOAVAILABILITY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISORDERS OF CARBOHYDRATE METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SUBSTRATE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN MODIFICATION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; ARGININE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PEROXIDASE;

EID: 79955602030     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100595     Document Type: Article

References (35)

1. Moncada, S. and Higgs, E. A. (2006) The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 147, S193-S201.
2. Vanhoutte, P. M., Shimokawa, H., Tang, E. H. and Feletou, M. (2009) Endothelial dysfunction and vascular disease. Acta Physiol. 196, 193-222.
3. Förstermann, U. (2010) Nitric oxide and oxidative stress in vascular disease. Pflugers Arch. 459, 923-939.
4. Tsikas, D., Böger, R. H., Sandmann, J., Bode-Böger, S. M. and Frölich, J. C. (2000) Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett. 478, 1-3.
5. Teerlink, T., Luo, Z., Palm, F. and Wilcox, C. S. (2009) Cellular ADMA: regulation and action. Pharmacol. Res. 60, 448-460.
6. Cardounel, A. J., Cui, H., Samouilov, A., Johnson, W., Kearns, P., Tsai, A. L., Berka, V. and Zweier, J. L. (2007) Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J. Biol. Chem. 282, 879-887.
7. Siroen, M. P., Teerlink, T., Nijveldt, R. J., Prins, H. A., Richir, M. C. and Van Leeuwen, P. A. (2006) The clinical significance of asymmetric dimethylarginine. Annu. Rev. Nutr. 26, 203-228.
8. Böger, R. H., Maas, R., Schulze, F. and Schwedhelm, E. (2009) Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality: an update on patient populations with a wide range of cardiovascular risk. Pharmacol. Res. 60, 481-487.
9. Bode-Böger, S. M., Scalera, F. and Ignarro, L. J. (2007) The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacol. Ther. 114, 295-306.
10. Libby, P., Ridker, P. M. and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation 105, 1135-1143.
11. Lind, L., Siegbahn, A., Hulthe, J. and Elmgren, A. (2008) C-reactive protein and E-selectin levels are related to vasodilation in resistance, but not conductance arteries in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 199, 129-137.
12. Vita, J. A., Brennan, M. L., Gokce, N., Mann, S. A., Goormastic, M., Shishehbor, M. H., Penn, M. S., Keaney, Jr, J. F. and Hazen, S. L. (2004) Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 110, 1134-1139.
13. Van der Zwan, L. P., Teerlink, T., Dekker, J. M., Henry, R. M., Stehouwer, C. D., Jakobs, C., Heine, R. J. and Scheffer, P. G. (2010) Plasma myeloperoxidase is inversely associated with endothelium-dependent vasodilation in elderly subjects with abnormal glucose metabolism. Metab. Clin. Exp. 59, 1723-1729.
14. Henry, R. M. A., Kostense, P. J., Spijkerman, A. M. W., Dekker, J. M., Nijpels, G., Heine, R. J., Kamp, O., Westerhof, N., Bouter, L. M. and Stehouwer, C. D. A. (2003) Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 107, 2089-2095.
15. Alberti, K. G. and Zimmet, P. Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539-553.
16. Teerlink, T., Nijveldt, R. J., De Jong, S. and Van Leeuwen, P. A. (2002) Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal. Biochem. 303, 131-137.
17. De Jong, S. and Teerlink, T. (2006) Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal. Biochem. 353, 287-289.
18. Grooteman, M. P., Gritters, M.,Wauters, I. M., Schalkwijk, C. G., Stam, F., Twisk, J., TerWee, P. M. and Nube, M. J. (2005) Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients. Nephrol. Dial. Transplant. 20, 2751-2758.
19. Scheffer, P. G., Van Der Zwan, L. P., Schindhelm, R. K., Vermue, H. P. A. and Teerlink, T. (2009) Myeloperoxidase concentrations in EDTA-plasma of healthy subjects are discordant with concentrations in heparin-plasma and serum. Clin. Biochem. 42, 1490-1492.
20. Van der Zwan, L. P., Teerlink, T., Dekker, J. M., Henry, R. M. A., Stehouwer, C. D. A., Jakobs, C., Heine, R. J. and Scheffer, P. G. (2009) Circulating oxidized LDL: determinants and association with brachial flow-mediated dilation. J. Lipid Res. 50, 342-349.
21. Holvoet, P., Mertens, A., Verhamme, P., Bogaerts, K., Beyens, G., Verhaeghe, R., Collen, D., Muls, E. and Van de Werf, F. (2001) Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 21, 844-848.
22. Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. L., Hendriksen, S., Kusek, J.W. and Van Lente, F. (2006) Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann. Intern. Med. 145, 247-254.
23. Wu, G. and Morris, Jr, S. M. (1998) Arginine metabolism: nitric oxide and beyond. Biochem. J. 336, 1-17.
24. Ryoo, S., Gupta, G., Benjo, A., Lim, H. K., Camara, A., Sikka, G., Lim, H. K., Sohi, J., Santhanam, L., Soucy, K. et al. (2008) Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ. Res. 102, 923-932.
25. Van Waardenburg, D. A., De Betue, C. T., Luiking, Y. C., Engel, M. and Deutz, N. E. (2007) Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation. Am. J. Clin. Nutr. 86, 1438-1444.
26. Palm, F., Onozato, M. L., Luo, Z. and Wilcox, C. S. (2007) Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am. J. Physiol. Heart Circ. Physiol. 293, H3227-H3245.
27. Kielstein, J. T., Salpeter, S. R., Bode-Böger, S. M., Cooke, J. P. and Fliser, D. (2006) Symmetric dimethylarginine (SDMA) as endogenous marker of renal function: a meta-analysis. Nephrol. Dial. Transplant. 21, 2446-2451.
28. Murray-Rust, J., Leiper, J., McAlister, M., Phelan, J., Tilley, S., Santa Maria, J., Vallance, P. and McDonald, N. (2001) Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase. Nat. Struct. Biol. 8, 679-683.
29. Luo, Z., Teerlink, T., Griendling, K., Aslam, S., Welch, W. J. and Wilcox, C. S. (2010) Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells. Hypertension 56, 498-504.
30. Nicholls, S. J. and Hazen, S. L. (2005) Myeloperoxidase and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 1102-1111.
31. Schindhelm, R. K., Van Der Zwan, L. P., Teerlink, T. and Scheffer, P. G. (2009) Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? Clin. Chem. 55, 1462-1470.
32. Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F. and Collen, D. (1998) Oxidized LDL and malondialdehydemodified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98, 1487-1494.
33. Van der Zwan, L. P., Scheffer, P. G., Dekker, J. M., Stehouwer, C. D. A., Heine, R. J. and Teerlink, T. (2010) Hyperglycemia and oxidative stress strengthen the association between myeloperoxidase and blood pressure. Hypertension 55, 1366-1372.
34. Singh, U., Devaraj, S. and Jialal, I. (2009) C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. Clin. Chem. 55, 361-364.
35. Singh, U., Devaraj, S., Vasquez-Vivar, J. and Jialal, I. (2007) C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J. Mol. Cell Cardiol. 43, 780-791.